Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma

British Journal of Cancer

Volumn 92, Issue 11, 2005, Pages 2024-2031

  Arnold, J M ^a   Huggard, P R ^a   Cummings, M ^b   Ramm, G A ^a   Chenevix Trench, G ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

5 aza 2 deoxycytidine; CCL2; In situ hybridisation; MCP 1; Ovarian adenocarcinoma; SSCP

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADVANCED CANCER; ARTICLE; CANCER GRADING; CARCINOGENESIS; CHROMOSOME 17Q; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE LOCUS; GENE SILENCING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOCARCINOMA; CHEMOKINE CCL2; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM STAGING; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 21244460674     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602596     Document Type: Article

References (54)

1. Arnold JM, Mok SC, Purdie D, Chenevix-Trench G (2001a) Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas. Br J Cancer 84: 1-8
2. Arnold JM, Cummings M, Purdie D, Chenevix-Trench G (2001b) Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer 85: 1351-1358
3. Aunoble B, Sanches R, Didier E, Bignon Y (2000) Major oncogenes and tumour suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 16: 567-576
4. Bottazzi B, Walter S, Govoni D, Colotta F, Mantovani A (1992) Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth and susceptibility to IL-2 therapy of a murine melanoma. J Immunol 148: 1280-1285
5. Buick RN, Pullano R, Trent JM (1985) Comparative proterties of five human ovarian adenocarcinoma cell lines. Cancer Res 45: 3668-3676
6. Burke F, Relf M, Negus R, Balkwill F (1996) A cytokine profile of normal and malignant ovary. Cytokine 8: 578-585
7. Colombo MP, Modesti A, Parmiani G, Forni G (1992) Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res 52: 4853-4857
8. Desbaillets I, Tada M, de Tribolet N, Diserens AC, Hamou MF, Van Meir EG (1994) Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer 58: 240-247
9. Duan Z, Feller AJ, Penson RT, Chabner BA, Seiden MV (1999) Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8 and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. Clin Cancer Res 5: 3445-3453
10. Fogh J, Trempe G (1975) New human cell lines. In Human tumour cells in vitro Fogh J (ed) pp 155-159. New York: Plenum
11. Goedegebuure PS, Douville CC, Doherty JM, Linehan DC, Lee K-Y, Ganguly EK, Eberlein TJ (1997) Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer. Cell Immunol 175: 150-156
12. Graves DT, Barnhill R, Galanopoulos T, Antoniades HN (1992) Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 140: 9-14
13. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF (1983) Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 43: 5379-5389
14. Hirose K, Hakozaki M, Nyunoya Y, Kobayashi Y, Matsushita K, Takenouchi T, Mikata A, Mukaida N, Matsushima K (1995) Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer 72: 708-714
15. Kleine-Lowinski K, Gillitzer R, Kuhne-Heid R, Rosl F (1999) Monocyte-chemo-attractant-protein-1 (MCP-1) gene expression in cervical intraepithelial neoplasias and cervical carcinomas. Int J Cancer 82: 6-11
16. Kuratsu J, Yoshizato K, Yoshimura T, Leonard EJ, Takeshima H, Ushio Y (1993) Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst 85: 1836-1839
17. Langdon SP, Lawrie SS, Hay FG, Hawkes MM, McDonald A, Hayward IP, Schol DJ, Hilgers J, Leonard RCF, Smyth JF (1988) Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res 48: 6166-6172
18. Liu Y, Ganesan TS (2002) Tumour suppressor genes in sporadic epithelial ovarian cancer. Reproduction 123: 341-353
19. Malik S, Balkwill F (1991) Epithelial ovarian cancer: a cyotkine propelled disease? Br J Cancer 64: 617-620
20. Mantovani A (1994) Biology of disease. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71: 5-16
21. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270
22. Mazzucchelli L, Loetscher P, Kappeler A, Uguccioni M, Baggiolini M, Laissue JA, Mueller C (1996) Monocyte chemoattractant protein-1 gene expression in prostate hyperplasia and prostate adenocarcinoma. Am J Pathol 149: 501-509
23. Merogi AI, Marrogi AI, Ramesh R, Robinson WR, Fermin CD, Freeman SM (1997) Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol 28: 321-331
24. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215
25. Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95: 2391-2396
26. Negus RPM, Stamp GWH, Hadley J, Balkwill FR (1997) Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150: 1723-1734
27. Nesbit M, Schaider H, Miller TH, Herlyn M (2001) Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumour formation in non-tumorigenic melanoma cells. J Immunol 166: 6483-6490
28. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K (1991) Properties of the novel proinflamatory supergene 'intercrine' cytokine family. Annu Rev Immunol 9: 617-648
29. O'Sullivan C, Lewis CE (1994) Tumor-associated leukocytes: friends or foes in breast carcinoma. J Pathol 172: 229-235
30. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841
31. Parmiani G, Anichini A, Fossati GJ (1990) Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy? J Natl Cancer Inst 82: 361-370
32. Penson RT, Kronishi K, Duan Z, Feller AJ, Stark P, Cook P, Duskat LR, Fuller AF, Goodman AK, Nikruh N, MacNeill KM, Matulonis UA, Preffers FI, Seiden MV (2000) Cytokines IL-1β, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFα in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Cancer 10: 33-41
33. Peoples GE, Davey MP, Goedegebuure PS, Schoof DD, Eberlein TJ (1995) T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer. J Immunol 151: 5472-5480
34. Ramm GA, Nair VG, Bridle KR, Shepherd RW, Crawford DHG (1998) Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol 153: 527-535
35. Rex M, Scotting PJ (1994) Simultaneous detection of RNA and protein in tissue sections by nonradioactive in situ hybridization followed by immunohistochemistry. Biochemica 3: 24-26
36. Riethdorf S, Riethdorf L, Richter N, Loning T (1998) Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastasis. Pathobiology 66: 260-267
37. Rollins BJ (1991) JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine. Cancer Cells 3: 517-524
38. Rollins BJ, Sunday ME (1991) Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol 11: 3125-3131
39. Rosl F, Lengert M, Albrecht J, Kleine K, Zawatzky R, Schraven B, Zur Hausen H (1994) Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hytbrids. J Virol 68: 2142-2150
40. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual 3rd edn New York: Cold Spring Harbour Laboratory Press
41. Shelling AN, Cooke IE, Ganesan TS (1995) The genetic analysis of ovarian cancer. Br J Cancer 72: 521-527
42. Sica A, Wang JM, Colotta F, Dejana S, Mantovani A, Oppenheim JJ, Larsen CG, Zachariae CO, Matsushima K (1990) Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 144: 3034-3038
43. Takeshima H, Kuratsu J, Takeya M, Yoshimura T, Ushio Y (1994) Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg 80: 1056-1062
44. Taub DD, Proost P, Murphy WJ, Anver M, Longo DJ, van Damme J, Oppenheim JJ (1995) Monocyte chemotactic protein-1 (MCP-1), -2 and -3 are chemotactic for human T lymphocytes. J Clin Invest 95: 1370-1376
45. Tsao S-W, Mok SC, Fey EG, Fletcher JA, Wan TSK, Chew E-C, Muto MG, Knapp RC, Berkowitz RS (1995) Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res 218; 499-507
46. Ward BG, Wallace K, Shepherd JH, Balkwill FR (1987) Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res 47: 2662-2667
47. Wilson AP (1984) Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary. J Natl Cancer Inst 72: 513-520
48. Wilson AP, Ford CHJ, Newman CE, Howell A (1987) Cis-platinum and ovarian carcinoma: in vitro chemosenstitvity of cultures tumour cells from patients receiving high dose cis-platinum as first line treatment. Br J Cancer 56: 763-773
49. Wolf CR, Hayward IP, Lawrie SS, Buckton K, McIntyre MA, Adams DJ, Lewis AD, Scott ARR, Smyth JF (1987) Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer 39: 695-702
50. Wong AST, Maines-Bandiear SL, Rosen B, Wheelock MJ, Johnson KR, Leung PCK, Roskelley CD, Auersperg N (1999) Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history on ovarian cancer. Int J Cancer 81: 180-188
51. Woods LK, Morgan RT, Quinn LA, Moore GE, Semple TU, Stedman KE (1979) Comparison of four new cell lines from patients with adenocarcinoma of the ovary. Cancer Res 39: 4449-4459
52. Zacchariae CO, Anderson AO, Thompson HL, Appella E, Mantovani A, Oppenheim JJ, Matsushima K (1990) Properties of a monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 171: 2177-2182
53. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty P, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. New Engl J Med 348: 203-213
54. Zhang L, Khayat A, Cheng H, Graves DT (1997) The pattern of monocyte recruitment in tumors is modulated by MCP-1 expression and influences the rate of tumor growth. Lab Invest 76: 579-590